DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tasigna (Nilotinib) - News

 
 



News related to Tasigna (Nilotinib) and/or conditions it is approved for

Experimental Immune Cell Rx Shows Promise for Leukemia
Source: MedicineNet Leukemia Specialty [2016.09.22]
Title: Experimental Immune Cell Rx Shows Promise for Leukemia
Category: Health News
Created: 9/21/2016 12:00:00 AM
Last Editorial Review: 9/22/2016 12:00:00 AM

Brain cancer and leukemia: New molecular mechanisms decoded
Source: Cancer / Oncology News From Medical News Today [2016.09.16]
A joint research published in Nature Communications has shown new molecular causes of brain cancer and leukemia.

Many adolescent girls with leukemia are not being screened for pregnancy before beginning chemotherapy
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.09.13]
A new study indicates that adolescent females with acute leukemia have low rates of pregnancy screening prior to receiving chemotherapy that can cause birth defects.

For Teens With Leukemia, Pregnancy Tests Often Neglected
Source: MedicineNet Birth Defects Specialty [2016.09.12]
Title: For Teens With Leukemia, Pregnancy Tests Often Neglected
Category: Health News
Created: 9/12/2016 12:00:00 AM
Last Editorial Review: 9/12/2016 12:00:00 AM

Cord-Blood Transplants Show Promise in Leukemia Treatment
Source: MedicineNet Leukemia Specialty [2016.09.08]
Title: Cord-Blood Transplants Show Promise in Leukemia Treatment
Category: Health News
Created: 9/7/2016 12:00:00 AM
Last Editorial Review: 9/8/2016 12:00:00 AM

Venetoclax safe, shows promise in patients with acute myelogenous leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.08.16]
Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2...

Researchers find open chromatin profiling key to identifying leukemia cells of origin
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.07.12]
Every cancer starts with a single cell, and Jackson Laboratory (JAX) researchers have found a precise and reliable way - whole-genome profiling of open chromatin - to identify the kind of cell that...

Relapse of leukemia after bone marrow transplantation: Cytomegalovirus infection has no protective effect
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.06.28]
Recent studies on a small number of patients with leukemia treated with bone marrow transplantation have suggested that the presence of the common cytomegalovirus (CMV) in patients or their donors...

Aggressiveness of acute myeloid leukemia elucidated
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.06.27]
Scientists at the Friedrich Miescher Institute for Biomedical Research (FMI) and the University of Basel have discovered why acute leukemias with the same genetic abnormality vary in their...

Texan is first adult in U.S. to receive updated stem cell transplant for leukemia treatment
Source: Transplants / Organ Donations News From Medical News Today [2016.06.14]
Texan Chuck Dandridge became the first adult in the U.S. to receive a newly modified stem cell transplant that uses genetically engineered blood cells from a family member, announced researchers at...

Leukemia
Source: MedicineNet Eosinophilic Fasciitis Specialty [2016.02.03]
Title: Leukemia
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 2/3/2016 12:00:00 AM

New benchmark study of unrelated bone marrow transplantation for leukemia
Source: The Doctors Lounge - Hematology
Researchers at the University of Minnesota led the largest study to date in patients with leukemia undergoing bone marrow transplantation from unrelated donors.

Researchers develop new strategy to limit side effects of stem cell transplants
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.08.16]
Scientists in Germany have developed a new approach that may prevent leukemia and lymphoma patients from developing graft-versus-host disease (GvHD) after therapeutic bone marrow transplants.

Cord blood outperforms matched, unrelated donor in bone marrow transplant
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.07.28]
A University of Colorado Cancer Center study compared outcomes of leukemia patients receiving bone marrow transplants from 2009-2014, finding that three years post transplant, the incidence of...

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015